Hormones compound antibody & antigen (hapten) for immunoassay and diagnostics rapid test

Hormones are a category of chemical substances that are produced by the endocrine glands in order to control certain operations in an organism. According to the structure and effects hormones are classified into several classes: steroid hormones, peptide/protein hormones and hormones built from amino acid derivatives. It has been possible to come up with several diagnostic and therapeutic techniques concerning hormonal disorders due to the identification and targeting of specific hormones. Hormone diagnostics and therapeutics are two sectors in which GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens products can dramatically make a change. This class of biologics has been established to be very selective and efficient in the identification and binding to hormones, thus regulating their impact on human health.

Based on GeneMedi’s goods, it possible to design diagnostic assay for detecting the presence of steroid hormones including testosterone, estrogen and cortisol, and to determine their concentration. Furthermore, it is also useful in the work on therapeutic remedies for the treatment of hormonal imbalances like the development of hormonal replacement therapy. Another group of similar importance includes peptide and protein hormones including insulin, the growth hormone, and the follicle stimulating hormone. With the help of GeneMedi’s product, peptide and protein hormones can be detected and quantified and the molecular targeting approach, like monoclonal antibodies to prevent and/or to cure hormonal disorders could be developed. The third category of hormones contains hormones based on amino acid, for instance, adrenaline and thyroxine. GeneMedi’s product can further the understanding of the physiological roles of amino acid derivative hormones and allow for the creation of diagnostic assays for the histological measurement of hormones and the creation of requisite receptor antagonists for the treatment and prevention of hormone associated diseases.

It is important to acknowledge that GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens products has great potential for changing the way that hormone diagnostics and therapeutics are conducted. This is because the classification and identification of specific hormones present the possibility of impact precision as well as signature therapies. It is important that hormonal disorder is diagnosed correctly in order to allow for the appropriate treatment and GeneMedi’s product could be useful for this. There are various methods by which one can detect and quantify small molecules of HORMONE from different samples and these include; ELISA, Lateral flow immunoassay (LFIA), colloidal gold Immunochromatographic assay, chemiluminescent immunoassay (CLIA), turbidimetric inhibition immunoassay (TINIA), immunonephelometry, and POCT. The product available in the market by GeneMedi has a huge market as it claims to revolutionize the future of hormone diagnostics and therapeutics which could greatly enhance patient requirements thus positively affecting the quality of life.